Wells Fargo analyst David Maris said Valeant Pharmaceuticals (NYSE: VRX) Wellbutrin XL distribution is unclear and more importantly, its pricing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE